Nephrology Review Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor

Nephrology Review
Leanna Tyshler, MD
Chronic Kidney Disease
Medical Advisor
Transplant Liaison
Syndromes of Renal Diseases
•
•
•
•
•
•
Acute Kidney Injury
Nephritic syndrome
Nephrotic syndrome
Asymptomatic proteinuria
Chronic Kidney Disease/ESRD
Asymptomatic hematuria
•
•
•
•
•
•
Urinary tract infection
Nephrolithiasis
Tumors
Electrolyte disturbances
Acid-Base problems
Hypertension
Acute Kidney Injury
• Rapid deterioration of renal function (48 hrs)
>0.3 mg/dl ↑ of Cr or >50% ↑ of Cr
UO < 0.5 mg/kg/h for 6 hrs
• Syndrome – common (20% all ICU patients)
–
–
–
–
High mortality/morbidity (about 50%)
Multifactorial
Non specific clinical symptoms
Decreased UO
• Oliguria: <400 ml of urine in 24 hrs
• Anuria: <100 ml of urine in 24 hrs
• Remember: 65% of patients are non-oliguric
– Abnormal labs
• Elevated BUN and Cr, “Azotemia” – accumulation of nitrogenous wastes
• Acid-base, electrolytes disturbance, fluid balance
Acute Kidney Injury
Pre-Renal
Renal
Post-Renal
Pre-Renal AKI – Decreased Renal Blood Flow
• Intravascular Volume Depletion
Blood loss
GI losses: vomiting, diarrhea, ↓ po intake
Skin losses: burns, sweat
Renal losses: DKA, DI, Addison’s, Na wasting, diuretics
• Decreased Effective Circulatory Volume
Decreased CO: CHF, PE, Tamponade
Hypotension: sepsis, shock, anaphylaxis, medication
Third Spacing: bowel obstruction, hepatorenal, nephrotic, surgery
Drug-induced: NSAIDs, CsA, FK506, ACEIs, ARBs
Vascular: renal artery compromise, AAA, atheroemboli, vasculitis
Acute Kidney Injury
Pre-Renal
Renal
Post-Renal
Causes of Obstructive Uropathy
A 75 y.o. man c/o not feeling well, abdominal
distension, and decreased urine. He was
recently started on amitriptyline for insomnia.
His creatinine is 5.1 (Cr 1.5 four months ago).
A 75 y.o. man c/o not feeling well, abdominal
distension, and decreased urine. He was
recently started on amitriptyline for insomnia.
His creatinine is 5.1 (Cr 1.5 four months ago).
1. What is the problem?
2. What do we need to do?
Bladder Outlet Obstruction
• Causes
– BPH
– Neurological disease
– Drugs
• Anticholinergic meds
• Pain meds
• Foley catheter insertion/renal US– diagnostic
• Post-obstructive diuresis
Acute Kidney Injury
Pre Renal
Vascular
Renal
Glomerular
Post Renal
Tubular
Ischemia
Toxins
Pigments
Interstitial
20 y.o. IDU with Endocarditis, Cr 3.7
Meds: Nafcillin, Gentamicin, Methadone, Ibuprofen
UA: 1+ protein, uNa 70. What is the dx?
What is the next step?
What is the diagnosis?
a) Acute Tubular Necrosis (ATN)
b) Acute Glomerulonephritis
c) Acute Interstitial Nephritis (AIN)
d) Nephrotic Syndrome
20 y.o. IDU with Endocarditis, Cr 3.7
Meds: Nafcillin, Gentamicin, Methadone, Ibuprofen
UA: 1+ protein, uNa 70
ATN due to Aminoglycosides
- Common
- Related to trough levels & duration; QD dosing
↓ toxicity; tissue half-life > serum half-life
- Risk factors
• Age, CKD, DM, volume depletion or
hypoperfusion, other toxic drugs
Contrast Nephropathy
• Renal vasoconstriction/hypoxia, iodine- toxic
• Risk Factors
– CRI, DM, hypovolemia
• 12-24 hrs post exposure, peaks in 3-5 days
• Non-oliguric, FeNa <1%
• Treatment/Prevention
– NS 1-1.5cc/kg/hr 12 hours pre/post
– Mucomyst (N-acetylcysteine), 600 mg BID pre/post
– Bicarbonate
A 66 y.o. man admitted with cellulitis, started on
Cefazolin. On hospital day 5, the pt’s Cr 2.7 (Cr 1.1
two months ago)
Other Labs: UA: 2+ WBCs, uNa=50, FeNa=1.5
What is your diagnosis?
Acute Interstitial Nephritis
What is the next step?
- Often drug induced NSAIDS, rifampin, abx
- 3-7 days after exposure
- Fever, rash, eosinophilia, AKI
- U/A: WBC, WBC casts + Hansel stain
- Tx: can resolve spontaneously, steroids
Acute Kidney Injury
Pre Renal
Vascular
Renal
Glomerular
Post Renal
Tubular
Ischemia
Toxins
Interstitial
GFR  Renin
Angiotensin
Blood Pressure
JGA
Normal Kidney
Glomerular Diseases
Primary
Glomerulonephritis
Secondary Systemic
Diseases
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Acute Diffuse Proliferative GN
Rapidly Progressive GN
Membranoproliferative GN
IgA Nephropathy
Minimal Change Disease
Membranous GN
FSGS
Chronic GN
Hereditary Disorders
• Alport’s syndrome
• Fabry’s disease
Systemic Lupus Erythematosus
Diabetes Mellitus
Amyloidosis
Goodpasture’s Syndrome
Polyarteritis Nodosa
Wagener’s granulomatosis
Henoch-Schonlein Purpura
Bacterial Endocarditis
Nephritic
•
•
•
•
•
•
Hematuria
Proteinuria
Hypoalbuminemia
GFR↓, Cr↑, BUN↑, Oliguria
Edema (salt/water retention)
Hypertension
Nephrotic
A 45 y.o. man with HTN, 2+B LE edema, rapidly
rising Cr and the following UA. What is the dx?
a)
b)
c)
d)
ATN
Acute Glomerulonephritis
Acute Interstitial Nephritis
Nephrotic Syndrome
Acute Post-Infectious GN
Acute Post Strep. GN, Acute Proliferative GN
• 8-14d after pharyn/skin inf w/Gr A B-hem strep, SBE, visceral
abscess, OM, sepsis
• Acute Nephritic Syndr: hematuria/HTN/edema/proteinuria
• RBC casts, dysmorphic RBCs, + antistreptolysin ASO/streptozyme
titer, low CH50/C3
• Pathology
– LM –enlarged, hypercellular glomeruli with endo/mes cell prolifer.
– IF –IgG, C3; coarsely gran along GBMs
– EM –subepithelial “hump-like” deposits
• Clinical Course/Tx
– 5% will progress to RPGN, 70% will recover
– Abx are not helpful except for ? family members
– Tx is supportive
Nephritic
Nephrotic
•
•
•
•
•
•
•
•
•
•
•
Hematuria
Proteinuria
Hypoalbuminemia
GFR↓, Cr↑, BUN↑, Oliguria
Edema (salt/water retention)
Hypertension
Proteinuria >3.5g/day
Hypoalbuminemia <3gm/dl
General edema
Hyperlipidemia
Lipiduria
Causes of Nephrotic Syndrome
Primary Glomerular Disease
Children(%)
Membranous GN
5
40
Minimal Change GN
65
15
Focal Segmental GN
10
15
MPGN
10
7
Other GN
10
23
Systemic Diseases
Diabetes Mellitus
Amyloid
Systemic Lupus Erythematosus
Adults(%)
Complications of Nephrotic Syndrome
• Infections
– Peritonitis, cellulitis, sepsis
• Thrombosis
– DVT, renal vein, arterial (kids)
• AKI
• Accelerated atherogenesis
• Protein depletion
Syndromes of Renal Diseases
•
•
•
•
•
•
Acute Kidney Injury
Nephritic syndrome
Nephrotic syndrome
Asymptomatic proteinuria
Chronic Kidney Disease/ESRD
Asymptomatic hematuria
•
•
•
•
•
•
Urinary tract infection
Nephrolithiasis
Tumors
Electrolyte disturbances
Acid-Base problems
Hypertension
Isolated Asymptomatic Proteinuria
Dipstick positive but no hematuria, pyuria
• R/o fever, exercise, UTI, CHF induced proteinuria
•  first AM spot U protein/creatinine (Up/c)
NKF of Hawaii, Spring 2007
• Estimate GFR or measure creatinine clearance (Ccr)
Up/c < 3.5 and nl GFR or Ccr
Non Nephrotic Proteinuria
Up/c > 3.5 and/or ↓GFR or Ccr
Nephrotic Proteinuria with or w/o CKD
 overnight recumbent Up/c
• Nephrology consult esp if no DM, HTN
• Serologic tests and/or renal biopsy
Up/c < 0.2 (neg)
Up/c = 0.2-0.5
Up/c > 0.5
Orthostatic Proteinuria
Tubular or Early Glom Proteinuria
Glom Proteinuria
Recheck 1y
UPEP x 1 to r/o protein dycrasia
Up/c spot AM, UA, GFR, BP q6 mo
Up/c stable, nl UA, GFR, BP
consider
Up/c ↑, ↓GFR, ↑ BP
Progressive Proteinuria +/- CKD
BP control, dietary Na, protein restrictions, consider ACEI/ARB, monitor q6-12 mo
Albuminuria: New Risk Factor/Marker
• High Prevalence:
• 7% of the general population
• 20% hypertensive population
• 40% diabetic population
• Easy and cheap to measure
• Mild decrease in GFR and Microalbuminuria can be
signs of mild CKD
Predicts later development of
heart disease, stroke and diabetes
Definitions of Normal & Abnormal
Urine Albumin
Dipstick
Protein
Spot Collection
24hr
Alb
mg
Prot Alb
24hr Timed
Prot coll.
mg µg/min
Normal
-
-
<0.03 or
<30mg alb/g Cr
<30
<150
<20
Microalbuminuria
-
+
0.03-0.3 or
30-300mg alb/g Cr
30-300
<500
20-200
Macroalbuminuria
+
+
>0.3 or
>300 mg alb/g Cr
>300
>500
>200
Basi et al, AJKD. Vol 47, No 6 2006: 927-946
Vascular Diseases
• Microvascular
– Benign nephrosclerosis
– Malignant hypertension/Malignant nephrosclerosis
– Thrombotic microangiopathies
• Macrovascular
– Aortic aneurysm
– Renal artery dissection or thrombosis
– Renal vein thrombosis
– Atheroembolic disease
Thrombotic Microangiopathy
(Microvascular AKI)
• Morphologic finding in several diseases
– Platelets form thrombi, deposit in kidneys
– Glomerular capillary occlusion/thrombosis
• Microangiopathic hemolytic anemia
Thickening of the arterial wall, hyperplastic
arteriolitis. The arteriole has an "onion skin"
appearance
• HUS, TTP, Malignant HTN, Systemic sclerosis
• Plasma exchange, steroids, IVIG,
splenectomy
Fibrinoid necrosis of small arteries. The
damage to the arteries leads to formation
of pink fibrin- hence the term "fibrinoid"
A 49 y.o. woman with Breast Cancer, s/p chemo with
weakness, fever, rash. WBC 16.4, Hct 22, Platelets
55, Cr 3.2, LDH 5750, CK 550. UA 3+ prot, 2+blood,
RBC. What is the dx?
a)
b)
c)
d)
Acute Glomerulonephritis
TTP (Thrombotic Thrombocytopenic Purpura)
Nephrotic Syndrome
Rhabdomyolysis
A 49 y.o. woman with BC, s/p chemo w/weakness, fever,
rash. WBC 16.4, Hct 22, Plat 55, Cr 3.2, LDH 5750, CK
550. UA 3+ prot, 2+blood, RBC. What is the dx?
What test do you order next?
– Order blood smear to r/o TTP
a)
b)
c)
d)
Acute GN
TTP
Nephrotic Syndrome
Rhabdomyolysis
• TTP associated with malignancy, chemo
• TTP may mimic GN on UA (RBCs, WBCs)
• Thrombocytopenia, anemia not consistent
with nephrotic/nephritic syndrome
• New CK in the thousands to cause ARF
Macrovascular ARF
•
•
•
•
•
Aortic Aneurysm
Renal artery dissection or thrombosis
B Renal artery stenosis
Renal vein thrombosis
Atheroembolic disease
– New onset or accelerated HTN?
– Abdominal bruits, reduced femoral pulses?
– Vascular disease?
– Embolic source?
A 68 y.o. male s/p cardiac cath 4 days ago, now with
Cr 1.6 (0.9 at baseline) and reddish-purplish mottling
of the skin. What is the dx?
a)
b)
c)
d)
Renal Artery Stenosis
Contrast-Induced Nephropathy
Abdominal Aortic Aneurysm
Cholesterol Atheroemboli
Atheroembolic ARF
• Occurs after intravascular procedures
(cardiac cath, CABG, AAA)
– emboli of fragments of atherosclerotic plaque from
aorta, other large arteries
• Dx
– Hx and PE-evidence of other emboli
• CVA, ischemic digits, “blue toe” syndrome/Livedo
Reticularis, mesenteric ischemia
– Low C3 and C4, eosinophilia, eosinophiluria,
rarely WBC casts
– Renal bx- rarely
• Tx: supportive
Acute Renal Infarct
Acute Kidney Injury: Work-up
Chem 7
Serum Cr
• Falsely ↑ with Septra, Cimetidine
• Small ↑ reflects large ↑ GFR
BUN/Cr Ratio
• Ratio 20:1- pre-renal
FeNa <1%:
PRERENAL
ATN (contrast, myoglobin)
Glomerular or vascular injury
FeNa >2%:
ATN -damaged tubules can't reabsorb
Loop diuretics cause natriuresis
Steroids, GIB, catabolic state, hypovolemia
• Ratio 10:1- intrinsic
BUN generally follows Cr ↑
Other tests:
Urine
• Lytes, osmolality, creat, protein
• Urine sediment: casts, cells
• FeNa = (urine Na x plasma Cr)
(plasma Na x urine Cr)
•
•
•
•
•
•
•
•
Renal US
24 hr urine for protein & creatinine
UPEP/SPEP
Cholesterol, albumin, glucose
ANA panel, ANCA, HIV, Hepatitis
B/C, ASO, PSA
Post-void residual or catheterization
Renal biopsy
Treatment of ARF
•
•
•
•
•
•
•
Eliminate the toxic insult
Hemodynamic support
Respiratory support
Fluid management
Electrolyte management
Medication dose adjustment
Dialysis
A 40 y.o. man with Rhabdo with K 5.9
• Is it real?
Pseudohyperkalemia
• Too much intake
Iatrogenic, salt substitute
• Too little excretion
Renal failure
Drugs that block renal K excretion
• ACEIs/ARBs, NSAIDs, Septra, Heparin
• Shift
Acidosis, hyperglycemia, muscle injury (rhabdomyolysis)
Hemolysis, very high WBC (leukemia), very high platelet count
What if K is 7.4?
• Highly arrhythmogenic
Progressive EKG changes
• Peaked T waves → Widened QRS → Sinus wave
• Emergent
IV calcium gluconate
• Urgent
IV HCO3
IV glucose and insulin
• Timely
Kayexalate
Furosemide
Dialysis
Indications for Dialysis
• Hyperkalemia
• Volume overload (resistant to diuresis)
• Metabolic acidosis
• Uremia
– Mental status changes
– Seizures
– Pericarditis
– Uncontrolled bleeding
• Toxins removable by dialysis
Syndromes of Renal Diseases
•
•
•
•
•
•
Acute Kidney Injury
Nephritic syndrome
Nephrotic syndrome
Asymptomatic proteinuria
Chronic Kidney Disease/ESRD
Asymptomatic hematuria
•
•
•
•
•
•
Urinary tract infection
Nephrolithiasis
Tumors
Electrolyte disturbances
Acid-Base problems
Hypertension
Prevalence of kidney failure
1996
USRDS, 2007
Prevalence of kidney failure
2006
USRDS, 2007
Chronic Kidney Injury, ESRD
The tip of the iceberg . . .
350,000 dialysis patients
30 million Americans
with CKD
ESRD by Dx
ESRD = End Stage Renal Disease
USRDS 2009
Diabetic Nephropathy
•
•
•
•
50% of DM1 & 40% DM2 patients
Progressive proteinuria; initially- increased GFR
30% of pts develop ESRD?
Diabetic Kidney Disease
Hyaline nodules
– Glomerulosclerosis, arteriolosclerosis → Hypertension
– Pyelonephritis, Papillary necrosis
• Test for microalbuminuria (30-300 mg/day)
– yearly at 5 years from dx for Type 1, dx for Type 2
• Tx:
–
–
–
–
ACEIs/ARBs
BP Control
BS Control
Tx of proteinuria
KW nodules
Autosomal Dominant PKD
• Common 1:1,000
• 10% of all transplant/dialysis patients
• ADPKD-1 gene (polycystin) mutation in 85%
• Symptoms appear in adult life
Bilaterally enlarged kidneys (>3,000g)
Liver (30%), splenic (10%) and pancreatic cysts (5%), cerebral
aneurysms (20%), diverticuli
• Renal failure 5-10 years thereafter
1 in 7 Adult Americans Have
Chronic Kidney Disease (CKD)
CKD
Stage
Kidney damage for ≥3 mo
eGFR < 60ml/min/1.73m2
albuminuria, hematuria
Number of
Individuals
1
Albuminuria with nl or increased
kidney function (≥90)
5.6 million
2
Albuminuria with mildly reduced
kidney function ( 60-89)
5.7 million
3
30-59
7.4 million
4
15-29
300,000
5
<15 or dialysis
431,284
eGFR = estimated glomerular filtration rate.
Coresh et al, J Am Soc Nephrol. 2005;16:180-188
eGFR
(mL/min/1.73 m2)
Chronic Kidney Disease
• NO SYMPTOMS
•
•
•
•
•
•
•
General – weakness, fatigue, pruritis
C.V. – hypertension, pericarditis
G.I. – anorexia, nausea, vomiting, diarrhea
CNS – lethargy, confusion, coma, neuropathy, asterexis
Muscles – twitching, weakness
Bones – osteodystrophy
Metabolic – acidosis, P↑, K↑, BUN↑, Cr↑
• Endocrine – parathyroids↑, vit D def
Chronic Kidney Disease
Premature Death
from
Cardiovascular
Disease
Kidney Failure
Foley,
Foley,RN,
RN,etetal,al,Am
AmJ JKidney
KidneyDis
Dis1998;32(suppl
1998;32(suppl3):S112-S119
3):S112-S119
How to Test for Chronic Kidney Disease
• Blood Pressure Measurement
• Estimated GFR from serum creatinine using the MDRD
prediction equation
• Urine microalbumin with a microalbumin dipstick or
“spot” urine albumin to creatinine ratio or standard
dipstick
*24 hour urine collections are NOT needed
1
Bouleware, et al., 2003
At what level of Creatinine does a 65y.o diabetic, hypertensive
white woman weighing 50 kg have CKD?
•
77% said:
Creatinine > 1.5 mg / dl
GFR = 37 mL/min/ 1.73 m2
Ccreat = 30 mL/min
•
Creatinine = 1.0 for GFR = 59 mL/min/1.73 m2
•
MDRD formula uses creatinine, age, gender, race, normalized
to average adult surface area
http://www.kidney.org/prifessionals/kdoqi/gfr calculator.cfm
Nat Kid Ed Prog, 2005
Intervention Makes a Difference
•
•
•
•
•
•
•
•
•
•
BP less than 130/80
Use of ACEI/ARB
Treatment of proteinuria
Treatment of diabetes
Attention to nutrition
Treatment of anemia
Treatment of hyperphosphatemia
Treatment of hyperlipidemia and other CV risk factors
Referring patients to a nephrologist
Proactive permanent AV fistula placement
Identifying Kidney Disease –
Protects the Heart
• Assess all patients for presence of CKD risk factors
• Screen all patients with CKD risk factors for CKD
• Identify etiology of CKD
• Evaluate all CKD patients for CKD complications
• Treat CKD-associated abnormalities both to optimize
cardiovascular status and to slow CKD progression and
Kidney Failure
• Consult with a nephrologist as needed
A 58 y.o. Caucasian male with a solitary kidney, referred for
primary care. PMH: DM X 20 years, diabetic retinopathy, HTN,
OA, s/p nephrectomy after trauma.
• Meds:
ASA 81 mg qd,
Lisinopril 5 mg qd,
HCTH 25 mg qd,
Simvastatin 10 mg qd, NPH 40u BID
• PE: 149/94, HR 74, 1+ edema
• Labs:
Na 139, K 5.0, Bun 66, Cr 2.5, Bicarb 27, Glu 194
Microalbumin/creat ratio: 950 mg/g creatinine
Hgb 8.1, Iron 45, % sat 18, ferritin 95
iPTH 125, PO4 5.6, Ca 9.0, Alb 4.5
Our Patient
•
CKD risk factors:
–
–
–
–
•
Screen for CKD:
–
–
–
•
Diabetes
Hypertension
Solitary kidney
OA ? NSAIDs
BP 149/94
Creat 2.5, eGFR 25 cc/min/1.73m2
Alb/Crea 950 mg/g creatinine
Etiology of CKD:
CKD and Diabetes
? Diabetic nephropathy
K/DOQI CKD Staging
Requires 2 or more GFR, 3 or more months apart
GFR
90
60
Other markers of kidney disease:
proteinuria, hematuria, anatomic
1
2
30
Complications
Possible
15
Complications
Evident
Renal
Replacement
4
5
3
CKD Stages
Evaluate All CKD Patients for
CKD Complications
• CVD, HTN, Proteinuria, Volume overload-may
be present at any eGFR
• Anemia, Metabolic Bone Disease, Acidosis,
Hyperkalemia, Malnutrition, Neuropathy-often
develop once eGFR less than 60ml/min/1.73m2
Our Patient
• HTN & Volume Management
• Cardiovascular Disease
149/94, edema
?
BP is associated with
• Rate of renal decline and risk of ESRD
• Stroke, myocardial infarction, & heart failure
Patients with Stage 4 CKD
(eGFR < 30ml/min/1.73m2)
• At high risk of deterioration in renal function
• Need counseling about modes of ESRD care, including
hemodialysis, peritoneal dialysis, and transplantation
• Need to be evaluated to construct an AV fistula
eGFR is less than 25 ml/min
Serum creatinine is greater than 4mg/dl
Guideline 8, KDOQI 2002
Primary Care Practitioners Have a Key
Lifesaving Role in Detecting Chronic
Kidney Disease— a Silent Heart Killer
• 1 in 7 Americans have CKD
• CKD is a known risk factor for CVD
• Most patients with CKD die from CVD
before they develop Kidney Failure
Syndromes of Renal Diseases
•
•
•
•
•
•
Acute Kidney Injury
Nephritic syndrome
Nephrotic syndrome
Asymptomatic proteinuria
Chronic Kidney Disease/ESRD
Asymptomatic hematuria
•
•
•
•
•
•
Urinary tract infection
Nephrolithiasis
Tumors
Electrolyte disturbances
Acid-Base problems
Hypertension
55 y.o. AA male with a hx of HTN comes after routine urinalysis
done for life insurance showed 2+ hematuria and 1+proteinuria.
• PE: BP 118/57, HR 63, o/w negative
• Labs: Repeat UA 2+ blood
Urine culture negative
R Cohen, R Brown,
NEJM 2003, 348-23
R Cohen, R Brown, NEJM 2003, 348-23
Dipstick positive for blood
Hematuria
Check U microscopy
RBCs > 2 RBC/HPF
Yes = Hematuria
No = Myoglobinuria or Hemoglobinuria
Check:
• CPK
• Myoglobin
• U free hemoglobin
With pyuria, bacteriuria = UTI
No RBC casts
No dysmorphic RBC
No bacteriuria
Antibiotic Rx if appropriate
Urology evaluation
If urological w/u –
Resolution
Persistant
Hematuria
With:
Dysmorphic RBC, RBC casts, Proteinuria
or ↓GFR
Nephrology consult
Possible renal biopsy
NKF of Hawaii, Spring 2007
Do all patients with hematuria need to be
evaluated by a nephrologist?
•
•
•
•
•
Dysmorphic RBC
RBC casts
Proteinuria
Decreased GFR
Hypertension
Consultation with a nephrologist should
be considered
• GFR< 30ml/min/1.73m2 (stage 4)  refer for RRT preparation
& transplant evaluation
• Rapid progression (loss of GFR>4 ml/min/1.73m2 per year)
• Diagnosis is unclear
• Co-managing of CKD complications
• Difficulty controlling blood pressure
• Proteinuria >1g per day
• Hematuria with RBC casts/dysmorphic RBCs, proteinuria, Htn
Syndromes of Renal Diseases
•
•
•
•
•
•
Acute Kidney Injury
Nephritic syndrome
Nephrotic syndrome
Asymptomatic proteinuria
Chronic Kidney Disease/ESRD
Asymptomatic hematuria
•
•
•
•
•
•
Urinary tract infection
Nephrolithiasis
Tumors
Electrolyte disturbances
Acid-Base problems
Hypertension
Acute Pyelonephritis
•
Bacterial infection (E. coli 80%)
•
Ascending/hematogenous
•
Lower UTI precedes renal infection
•
Fever, flank pain, neutrophilia
•
Leukocyte casts in urine
•
Healing - recurrence→ chronic
pyelonephritis
Acute Pyelonephritis with papillary necrosis (diabetes)
Predisposing Factors for Pyelonephritis
• Urolithiasis
• Reflux
• Infections of lower UT
• Neoplasms
• Ureteric, vesical, prostatic
• External compression
• Pregnancy, retroperitoneal fibrosis
Urolithiasis
• Incidence: 1-5%, males predominance
• Etiology: environmental, metabolic, infectious
• Clinical features
Ca oxalate is the most common
Silent/ Renal colic/ Dull ache in loins
Gross or micro hematuria
May recur
Complications: Obstruction/ hydronephrosis/ hydroureter/
recurrent UTI
• Treatment
Adequate hydration, low salt diet
Tx of metabolic abnl (hypocitraturia, hypercalciuria)
Surgery, lithotripsy
Hydronephrosis
Renal Cell Carcinoma— Most Common Renal Tumor
• Peak age – 60y, M:F = 3:1
• Risk factors
• Tobacco; Obesity, Genetics
• VHL gene, familial
• Classical triad < 10%
– Hematuria, flank pain, mass
• Hematuria 50%
– Most common symptom
• Metastases
– Hematogenous/local abdominal
• Paraneoplastic syndromes
– PTH, Epo, amyloid
• 5 year survival 40%